Abstract:In vitro cultures of primary cardiac fibroblasts (CFs), the major extracellular matrix (ECM)-producing cells of the heart, are used to determine molecular mechanisms of cardiac fibrosis. However, the supraphysiologic stiffness of tissue culture polystyrene (TCPS) triggers the conversion of CFs into an activated myofibroblast-like state, and serial passage of the cells results in the induction of replicative senescence. These phenotypic switches confound the interpretation of experimental data obtained with cultured CFs. In an attempt to circumvent TCPS-induced activation and senescence of CFs, we used poly(ethylene glycol) (PEG) hydrogels as cell culture platforms with low and high stiffness formulations to mimic healthy and fibrotic hearts, respectively. Low hydrogel stiffness converted activated CFs into a quiescent state with a reduced abundance of α-smooth muscle actin (α-SMA)-containing stress fibers. Unexpectedly, lower substrate stiffness concomitantly augmented CF senescence, marked by elevated senescence-associated β-galactosidase (SA-β-Gal) activity and increased expression of p16 and p21, which are antiproliferative markers of senescence. Using dynamically stiffening hydrogels with phototunable cross-linking capabilities, we demonstrate that premature, substrate-induced CF senescence is partially reversible. RNA-sequencing analysis revealed widespread transcriptional reprogramming of CFs cultured on low-stiffness hydrogels, with a reduction in the expression of profibrotic genes encoding ECM proteins, and an attendant increase in expression of NF-κB-responsive inflammatory genes that typify the senescence-associated secretory phenotype (SASP). Our findings demonstrate that alterations in matrix stiffness profoundly impact CF cell state transitions, and suggest mechanisms by which CFs change phenotype in vivo depending on the stiffness of the myocardial microenvironment in which they reside.NEW & NOTEWORTHY Our findings highlight the advantages and pitfalls associated with culturing cardiac fibroblasts on hydrogels of varying stiffness. The findings also define stiffness-dependent signaling and transcriptional networks in cardiac fibroblasts.

3D matrix stiffness modulation unveils cardiac fibroblast phenotypic switching

Effects of Fibroblast on Cardiac Electro-Mechanics: A Cube Modeling Study

Substrate Stiffness Alters Human Induced Pluripotent Stem Cell-derived Cardiomyocyte Differentiation and Maturation

Substrate stiffness modulates cardiac fibroblast activation, senescence, and proinflammatory secretory phenotype

Substrate Stiffness-Regulated Matrix Metalloproteinase Output in Myocardial Cells and Cardiac Fibroblasts: Implications for Myocardial Fibrosis.

Cellular Alignment and Matrix Stiffening Induced Changes in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes

Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation.

A positive mechanobiological feedback loop controls bistable switching of cardiac fibroblast phenotype

Fiber Networks: the Plasticity of Nanofibrous Matrix Regulates Fibroblast Activation in Fibrosis (adv. Healthcare Mater. 8/2021)

GelMA hydrogel dual photo-crosslinking to dynamically modulate ECM stiffness

Matrix Stiffness Controls Cardiac Fibroblast Activation Through Regulating YAP Via AT1 R.

Stiffness assisted cell-matrix remodeling trigger 3D mechanotransduction regulatory Programs to induce stem cell differentiation

In Situ Regulation and Mechanisms of 3D Matrix Stiffness on the Activation and Reversion of Hepatic Stellate Cells.

Matrix stiffness in three-dimensional systems effects on the behavior of C3A cells.

Matrix Stiffness Regulates SMC Functions Via TGF-β Signaling Pathway

Increased Matrix Stiffness Promotes Fibrogenesis of Hepatic Stellate Cells Through AP-1-induced Chromatin Priming

Mechanical control of cardiac myofibroblasts

A Role for Matrix Stiffness in the Regulation of Cardiac Side Population Cell Function.

Matrix stiffness changes affect astrocyte phenotype in an in vitro injury model

Mechanoregulation of Cardiac Myofibroblast Differentiation: Implications for Cardiac Fibrosis and Therapy

Matrix Stiffness Regulates Myocardial Differentiation of Human Umbilical Cord Mesenchymal Stem Cells